Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness

BACKGROUND: In a prospective study with long-term follow-up, we analyzed circulating T cell subsets in patients with metastatic colorectal cancer (mCRC) in the context of primary tumor sidedness, KRAS status, and clinical outcome. Our primary goal was to investigate whether baseline levels of circul...

Descripción completa

Detalles Bibliográficos
Autores principales: Bencsikova, Beatrix, Budinska, Eva, Selingerova, Iveta, Pilatova, Katerina, Fedorova, Lenka, Greplova, Kristina, Nenutil, Rudolf, Valik, Dalibor, Obermannova, Radka, Sheard, Michael A., Zdrazilova-Dubska, Lenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631500/
https://www.ncbi.nlm.nih.gov/pubmed/31307428
http://dx.doi.org/10.1186/s12885-019-5909-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631500/
https://www.ncbi.nlm.nih.gov/pubmed/31307428
http://dx.doi.org/10.1186/s12885-019-5909-5

Ejemplares similares